Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Ceapro Inc V.CZO

Ceapro Inc. is a Canada-based biotechnology company. The Company is involved in the development of extraction technology and the application of this technology to the production of extracts and active ingredients from oats and other renewable plant resources. Its primary business activities relate to the development and commercialization of natural products for personal care, cosmetic, human, and animal health industries using technology, natural, renewable resources, and developing products, technologies, and delivery systems. The Company's products include a commercial line of natural active ingredients, including beta glucan, avenanthramides (colloidal oat extract), oat powder, oat oil, oat peptides, and lupin peptides, a commercial line of natural anti-aging skincare products, utilizing active ingredients, including beta glucan and avenanthramides and veterinary therapeutic products, including an oat shampoo, an ear cleanser, and a dermal complex/conditioner.


TSXV:CZO - Post by User

Comment by Tencentson Jan 04, 2024 9:38am
49 Views
Post# 35810274

RE:RE:RE:RE:RE:RE:A Mickey Mouse Deal / CoQ10 Deal?

RE:RE:RE:RE:RE:RE:A Mickey Mouse Deal / CoQ10 Deal?The reason it would achieve a large value even at early stage is that the solution targeted a huge unmet medical need with 28 million patients and no alternative solution
its expected to be a multi billion $ drug
the amount of research costs were not indicatif of the potentiel 
Bellus had nailed the value creating strategy and probably knew big pharma was lining up to get the drug 
<< Previous
Bullboard Posts
Next >>